A Phase II Study to Evaluate Efficacy and Safety of P276-00 in Relapsed and/or Refractory Mantle Cell Lymphoma
Clinical trial NCT00843050 · TERMINATED
Trial details
- NCT number
- NCT00843050
- Sponsor
- Piramal Enterprises Limited
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-11-01
- Primary completion
- 2011-02-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.